Thomas M. Patton
President and Chief Executive Officer
Mr. Patton joined CASMED in August 2010 as President and CEO. Previously, Mr. Patton acted as an advisor to the healthcare-focused private equity group of Ferrer Freeman & Company, LLC and as CEO of QDx, Inc., a successful start-up that developed a revolutionary platform for hematology diagnostics. Mr. Patton has previously served as the CEO of Wright Medical Group, an orthopedic device company in Memphis, Tennessee, and as President of Novametrix Medical Systems, a patient monitoring company in Wallingford, Connecticut. He started his career at the law firm of Williams and Connolly in Washington, D.C. Mr. Patton has served on the Board of Directors of more than a dozen public and private companies and is currently the Lead Director of Misonix, Inc. He graduated from The College of the Holy Cross and magna cum laude from Georgetown University Law Center.
Executive Vice President of US Sales
Ms. Strusky joined CASMED in September 2015 as Senior Vice President of US Sales. Ms. Strusky has over twenty years of professional experience in conceptual and clinical selling, sales management, strategic planning, new market development and sales training. After spending eight years with Baxter Healthcare and eight years with STERIS Corporation, Ms. Strusky propelled start up Aspect Medical Systems from $15 million to $70 million in domestic brain monitoring sales capturing the market leadership position. Prior to joining CAS Medical in 2015, she was Vice President of U.S. Sales for CSA Medical where she was instrumental in commercializing the next generation Spray Cryotherapy System. Kim is adept at spearheading a $200 million sales organization, post-acquisition integration, building clinical teams, and creating strategies to drive results. Ms. Strusky is a graduate of Purdue University with a Bachelor of Science in Management.
Executive Vice President of International Sales
Ms. Harris-Coleman joined CAS Medical in September 2013 as Executive Vice President of International Sales with thirty years of experience in the medical device industry. Prior to joining CASMED, Karen consulted and worked with a number of start-up medical device companies in a variety of disciplines including pediatric vision care, respiratory care, and biomaterials. Before that she served as Sr. Vice President International for Wright Medical from 2001 until 2011, running the Pacific Rim and Latin America division of 125 employees with annual revenue reaching $100M. During her tenure at Wright, she launched the Japanese Subsidiary as well as converted the Australian business to an agent model - both of which were cash flow positive in under 12 months. Prior to her time at Wright, she ran International Sales & Marketing for MicroAire Surgical Instruments, a privately held company specializing in power surgical instruments.
Patrick C. Helfrich
Vice President of Global Marketing
Mr. Helfrich joined CASMED in 2011 as the Senior Director of Global Marketing and was appointed the Vice President of Global Marketing in 2014. He has more than 25 years of experience in sales, marketing, product development, business development, M&A, and finance in the medical device sector in a wide range of medical markets, surgical disciplines, and medical specialties. Previously, Mr. Helfrich was a 20-year veteran across multiple divisions of the United States Surgical Corporation and Covidien (now Medtronic) holding a wide range of commercial, business development, and finance positions. Most recently, he served as the Global Marketing Director for the Surgical Instrumentation Franchise with annual revenues of approximately $1B. He received his Masters of Business Administration from Northeastern University in Boston, MA and his Bachelor of Arts in Business from Saint Anselm College in Manchester, NH.
Dr. John K. Gamelin
Vice President of Research and Development
Mr. Gamelin joined CASMED in 2009, became the Director of Research and Development in 2010, and was appointed to Vice President of Research and Development in 2012. He has more than 20 years of experience inventing and developing optical, acoustic, and electronic instrumentation, from research concept to commercial production. Previously, as a co-founder and Vice President of Engineering for Tellium, an optical switching company, he was instrumental in driving that company from start-up to over $100 million in revenues in just four years. He began his career as a Senior Scientist at Bellcore, the research and engineering organization for the Regional Bell Operating Companies. Dr. Gamelin holds four U.S. patents in optical cross-connects and switching technology and several patent applications in biomedical imaging and medical instrumentation. He is the author or co-author of more than 50 publications on topics that include biomedical imaging and laser transmitters. He received his Ph.D. in electrical engineering from the University of California and was Valedictorian for his graduating undergraduate class at the University of Florida.
Jeffery A. Baird
Chief Financial Officer
Mr. Baird joined CASMED in January 2004 as Chief Financial Officer. He has over 25 years of extensive financial management experience in the medical products industry. Before joining CASMED, Mr. Baird was CFO of QDx, Inc., a start-up venture engaged in the development of a revolutionary platform for hematology diagnostics. Prior to his tenure at QDx, Mr. Baird held various financial positions at Novametrix Medical Systems including Controller, Treasurer, and CFO. Before joining Novametrix, Mr. Baird was employed by Philips Medical Systems.
Dr. Paul B. Benni
Chief Scientific Officer
Dr. Paul B. Benni joined CASMED in 1998, and in 2006 became Chief Scientific Officer. Dr. Benni is the primary inventor of the company’s FORE-SIGHT® Tissue Oximeter, a near-infrared spectroscopy (NIRS) -based device to monitor the oxygen saturation of the brain and other tissues of the human body non-invasively by using various wavelengths of light. With the support of several grants from the National Institutes for Health for his unique approach, Dr. Benni made possible the development and first commercialization of FORE-SIGHT for CASMED in 2007. Guided by Dr. Benni’s continued refinement of the technology and algorithms, the performance of the FORE-SIGHT monitor continues to define the category. Dr. Benni graduated from Rutgers, The State University of New Jersey, in 1990 with a B.S. in Electrical Engineering and in 1999 with a Ph.D. in Biomedical Engineering focused on NIRS research. Prior to attending graduate school, Dr. Benni worked as an engineer with GE Astrospace on satellites and the Mars Observer spacecraft. Dr. Benni holds several patents on NIRS technology and authored several peer-reviewed journal articles on the topic.